MedPath

Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

Not Applicable
Completed
Conditions
Aortic Aneurysm, Abdominal
Interventions
Device: Endurant Stent Graft System
Registration Number
NCT01379222
Lead Sponsor
Medtronic Cardiovascular
Brief Summary

The purpose of the study is to demonstrate the long term safety and effectiveness of the Endurant Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms in a post-approval environment, through the endpoints established in this protocol.

The clinical objective of the study is to evaluate the long term safety and effectiveness of the Endurant Stent Graft System assessed at 5 years through freedom from Aneurysm-Related Mortality (ARM).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
178
Inclusion Criteria
  • Age ≥18 years
  • Indication for elective surgical repair of abdominal aortic aneurysm (AAA) with an endovascular stent graft in accordance with the applicable guidelines on endovascular interventions and the Instructions for Use of the Endurant Stent Graft System
  • Signed consent form. The subject or legal representative has been informed of the nature of the trial and has consented to participate and authorized the collection and release of his medical information
  • Intention to electively implant the Endurant Stent Graft System
  • Ability and willingness to comply with the Clinical Investigational Plan (CIP).
Exclusion Criteria
  • High probability of non-adherence to physician's follow-up requirements
  • Current participation in a concurrent trial which may confound study results
  • Female of childbearing potential in whom pregnancy cannot be excluded or who is lactating.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ENGAGE PAS De Novo SubjectsEndurant Stent Graft SystemThe Endurant Stent Graft System Bifurcated device is administered to patients diagnosed with an abdominal aortic or aortoiliac aneurysm who are considered candidates for endovascular repair, per the FDA approved Instructions For Use (IFU).
Primary Outcome Measures
NameTimeMethod
Freedom From Aneurysm-related Mortality Rate (ARM) at 5 Years (1826 Days)5 years

Aneurysm-Related Mortality (ARM) is defined as death from rupture of the abdominal aortic aneurysm or from any procedure intended to treat the Abdominal Aortic Aneurysm (AAA). If a death occurred within 30 days of any procedure intended to treat the AAA, then it is presumed to be aneurysm related unless there is evidence to the contrary. Deaths occurring after 30 days of any procedure intended to treat the AAA that are procedure-related should be aneurysm related.

\> All deaths will be adjudicated by a Clinical Events Committee (CEC) to determine device, procedure and/or AAA relatedness.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (24)

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Morristown Memorial Hospital

🇺🇸

Morristown, New Jersey, United States

University of Pittsburgh Medical Center UPMC Shadyside

🇺🇸

Pittsburgh, Pennsylvania, United States

Baylor Jack and Jane Hamilton Heart and Vascular Hospital

🇺🇸

Dallas, Texas, United States

CHI Saint Luke's Health - Baylor Saint Luke's Medical Center

🇺🇸

Houston, Texas, United States

Inova Fairfax Hospital

🇺🇸

Falls Church, Virginia, United States

Ronald Reagan UCLA Medical Center

🇺🇸

Los Angeles, California, United States

Mercy Hospital and Medical Center

🇺🇸

Chicago, Illinois, United States

Medical Center of Central Georgia (MCCG)

🇺🇸

Macon, Georgia, United States

Bayfront Medical Center

🇺🇸

Saint Petersburg, Florida, United States

Novant Health Forsyth Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Lehigh Valley Hospital - Cedar Crest

🇺🇸

Allentown, Pennsylvania, United States

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

University of Virginia Medical Center

🇺🇸

Charlottesville, Virginia, United States

Sanford Medical Center Fargo

🇺🇸

Fargo, North Dakota, United States

WakeMed Health & Hospitals

🇺🇸

Raleigh, North Carolina, United States

Stanford Hospital & Clinics

🇺🇸

Stanford, California, United States

Southern Illinois University School of Medicine

🇺🇸

Springfield, Illinois, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

Aurora Saint Luke's Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

Physicians Regional Medical Center

🇺🇸

Knoxville, Tennessee, United States

The Christ Hospital

🇺🇸

Cincinnati, Ohio, United States

Parkwest Medical Center

🇺🇸

Knoxville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath